Latest Administration News

Orezone Gold Corporation has successfully completed its initial public offering on the ASX, raising A$75 million to fund expansion at its Bomboré Mine. The company's CHESS Depository Interests started trading under the ticker 'ORE' on August 8, 2025.

Pinnacle Minerals Limited’s PIMOA securities have been suspended from ASX quotation due to non-compliance with key listing rules, raising questions about the company’s regulatory standing.

Bravura Solutions Limited reported a robust FY25 with revenue growth of 3.1% and a 177% increase in underlying net profit, driven by operational efficiencies and a one-off software licence sale. The company announced a special dividend and continues its leadership transition with an interim CEO in place.

One Click Group Limited has reported a record-breaking July with $3 million in revenue and $1.4 million in EBIT, marking a 34% increase on the prior period and profitability for the first seven months of 2025.

EBR Systems has secured FDA approval for its pioneering leadless WiSE CRT System and obtained key Medicare reimbursement endorsements, setting the stage for its commercial rollout. The company also completed a significant capital raise to support its market expansion.

Insurance Australia Group (IAG) reported a robust FY25 with strong premium growth, improved margins, and strategic acquisitions pending regulatory approval. The company projects continued growth and margin stability into FY26.

Nutritional Growth Solutions Ltd has clarified discrepancies in its June 2025 quarterly reports, attributing changes to timing and classification adjustments, while reaffirming its financial health and governance compliance.

WAM Capital Limited’s July 2025 update reveals a robust net tangible asset position and a healthy interim dividend, underpinned by strong performances from key holdings ALS and HUB24.

Opyl Limited has formalized its partnership with UK-based Innovatrix Capital, positioning its AI platform TrialKey at the forefront of clinical trial failure insurance. This deal not only validates Opyl’s technology but also opens doors to global biotech markets and valuable data streams.

Platinum Asia Investments Limited (PAI) held a pivotal Scheme Meeting seeking shareholder approval to restructure by exchanging shares for units in the Platinum Asia Fund Complex ETF (PAXX), accompanied by a special dividend payment. The outcome will reshape PAI’s investment management and ownership structure.

Resouro Strategic Metals reports a significant update to its Tiros project resource alongside a reduced quarterly loss, highlighting progress in its Brazilian exploration assets.

Anteris Technologies reported solid clinical progress with 130 patients implanted with its DurAVR heart valve and is gearing up for its pivotal PARADIGM trial with 79 qualified sites worldwide. The company also strengthened its leadership with two new board members amid ongoing FDA engagement.